Purpose: Ocular regional blocks generally require blind instrumentation to the posterior orbit, leading to rare but serious complications. However, topical anesthesia does not suppress eye or lid movements and may lead to more surgical complications. Advanced subconjunctival anesthesia (ASCAN) is a technique developed to provide reliable akinesia and anesthesia without anterior dissection or blind intrusion into the posterior orbit, while allowing visualization of the needle-tip position.
neurovascular and eye injury led to the introduction of peribulbar anesthesia in 1986 4 as a somewhat safer alternative, by injecting into the extraconal space with a larger volume of anesthetic. Topical and intracameral anesthesia do not suppress eye movements but may lead to more surgical complications compared with sub-Tenon's anesthesia. 5 Sub-Tenon's anesthesia as described by Stevens 6 in 1992 has become a popular form of ocular anesthesia involving dissection of the inferonasal conjunctiva and advancing a blunt cannula along the sub-Tenon's plane into the retrobulbar space. This technique has been shown in a large study 7 and recent review article 8 to produce fewer serious complications than peribulbar and retrobulbar injections 9 though some 10 still occur. 11, 12 However, it requires more instrumentation including speculum, conjunctival forceps, scissors, and specialized cannula, along with more anatomical disruption.
In our institution, we developed a technique of single injection of a larger volume of anesthetic into the subconjunctival and anterior sub-Tenon's space to achieve a similar end (Fig. 1) . Correct needle placement can be visually confirmed and no dissection or posterior instrumentation is required. We called this technique advanced subconjunctival anesthesia (ASCAN). The purpose of this case series is to describe the ASCAN technique and to investigate its efficacy in providing reliable akinesia and anesthesia to elective patients having phacoemulsification surgery.
MATERIALS AND METHODS
After receiving approval from the regional Scientific and Human Ethics Research Committee (HERC), 60 suitable and consenting adult patients for cataract surgery under local anesthesia were recruited from the elective waiting list of a regional hospital. Allergy to relevant drugs, inability to cooperate or consent, children, and those with clinical contraindications were excluded.
Half of all patients received lignocaine 2%, whereas the other half had an equal mixture of lignocaine 2% and bupivacaine 0.5% The 2 different local anesthetics used reflect clinical practice in our institution. It is not our intention to investigate detailed differences between the 2 groups.
Patients were prepared for surgery according to standard procedures of the hospital. All patients remained on their usual antiplatelet and anticoagulant medications.
The first author performed ASCAN injections, whereas the second author performed phacoemulsification cataract surgery in all study subjects. An assistant independently scored for pain, eye movements, and visual acuity.
ASCAN INJECTION TECHNIQUE
Light sedation with midazolam is used optionally according to patient preference 5 minutes before ASCAN injection.
The eye and lids are prepared with 5% povidone-iodine solution. One or 2 drops of amethocaine 1% (Bausch & Lomb, USA) is instilled shortly before ASCAN injection. The patient lies in a supine position with the anesthetist standing beside the patient's relevant eye. An assistant gently holds the patient's head in case of unexpected movement. The upper lid is drawn widely open by the anesthetist. The patient is asked to look slightly inferomedially to expose the area of injection. A 10 mL syringe containing a solution of local anesthetic and 300 IU of hyaluronidase (Sanofi-Aventis, CP Pharmaceuticals, Wrexham, UK) fitted with a 25-gauge 16 mm needle (Beckton Dickinson, BD Precision Glide, Singapore) is prepared. In the superotemporal quadrant, at 5 to 7 mm from limbus, the needle is placed on the conjunctiva with the bevel down facing the sclera to avoid perforation. At this point, the Tenon's capsule is loosely attached to the sclera, such that it and the conjunctiva will both form a fold up in front of the needle tip as it is gently swept along. Operating loupes may be used optionally for clarity. Once the conjunctiva and Tenon's capsule are pierced, the needle tip is then advanced about 1 to 2 mm tangentially along the curve of the sclera. After visually checking needle position, inject to form a small bleb before the needle is advanced a further 2 to 5 mm superomedially along the episcleral plane within the bleb.
In its final position, the needle is pointing posteronasally to direct the anesthetic into the sub-Tenon's space (Fig. 2) . The hub of the needle can rest along the lateral orbital margin to stabilize its position. The body of the needle should be resting on the sclera in a tangential manner. The needle tip should be mobile in the lateral and vertical planes. A test injection of a small bleb of anesthetic should occur with minimal resistance. The injection is given very slowly while the eyelid is allowed to rest.
Guided by patient comfort with pauses as required, a total of 5 to 10 mL of solution is injected over a minute or so, to an endpoint determined by 3 clinical signs: moderate proptosis, lid fullness, and late spread of chemosis. Anterior placement of the needle or injecting too quickly will result in early chemosis.
Proptosis is the best indicator that the injected solution has reached the posterior orbit and thus is likely to produce a successful block. Early proptosis is often noticeable after 2 to 3 mL and continues to increase as more volume is given. The globe should be soft and ballotable at all times.
The needle is then withdrawn and gentle finger pressure is applied to the injection site for a minute or longer as needed, to minimize subconjunctival hemorrhage. Concurrently, with the other hand, gentle slow digital compression is applied around the gutter areas between the globe and orbital rim to reduce chemosis to a minimum. Supplemental injections may be given on patient or surgeon request.
DATA COLLECTION
Ocular akinesia was assessed using a scale based on one first described by Brahma et al, 13 which has been used successfully in other studies.
14,15 A motor score for eyelid and globe movements in 4 directions (nasal, temporal, superior, and inferior) is assessed by an independent observer preoperatively and 10 minutes after ASCAN injection. A motor score of 3 represents full movement, 2 for partial movement, 1 for twitch movement less than 1 mm, and 0 for no movement. A maximum Aggregated Motor Score (AMS) of 15 represents normal movement, whereas a minimum score of 0 represents total akinesia of the globe and lids.
Pain was assessed using a verbal Numeric Rating Scale, 16 where 0 represented no pain, 1 to 3 for degrees of mild pain, 4 to 6 for moderate pain, 7 to 9 for severe to excruciating pain, and 10 for the worst pain imaginable. Pain was scored during surgery as it occurred, then separately during subconjunctival injection of 0.5 mL suspension in equal proportion of gentamicin (80 mg/mL, Hospira Australia Pty Ltd) and betamethasone (Celestone Chronodose Suspension 5.7 mg/mL, Schering-Plough Pty Ltd) at the end of the operation in the inferotemporal quadrant. Gross visual acuity was scored to indicate optic nerve anesthesia 10 minutes after ASCAN. A score of 3 was given for patients able to count fingers at 1 meter, 2 for hand movement perception, 1 for light perception, and 0 for no light perception. 
RESULTS
Sixty patients were enrolled and all completed this study. Demographic, globe length, and timeline data are provided in Table 1. The mean duration from ASCAN injection to completion of surgery was 46 minutes and none required supplemental anesthesia. Fifty-one patients received midazolam, with a median dose of 2.2 mg per patient. Mean anesthetic volume injected was 9.6 mL (range, 6-10 mL).
Akinesia
Total lid block was achieved in all patients with no case of blepharospasm (Fig. 3) . Ninety-five percent of patients had an AMS of 4 or less, which is quoted in other studies to indicate adequate akinesia. One patient with an AMS of 7 had multiple previous lid surgeries resulting in difficulties opening the upper lid sufficiently. Two patients had an AMS of 5; one had a history of "resistance to local anesthetics," and the other had unintended double puncture of the conjunctiva causing local anesthetic to partially leak out.
Pain
During surgery, 58 of 60 patients had no pain. One patient with multiple previous surgeries to the lids had a pain score of 2, and another had a pain score of 1. Both instances of pain occurred near the end of surgery, but both completed surgery without difficulty or need for supplemental anesthesia. Pain scores during subconjunctival gentamicin injection at the end of surgery were quite different between the 2 groups (Fig. 4) . In the lignocaine group, 5 patients (16.6%) reported pain scores higher than 2, compared with 0 in the bupivacaine/lignocaine group. Although there is a trend, it was not statistically significant (P = 0.052). The most likely explanation for this is the shorter duration of action of lignocaine. This pain was transient, lasting a few seconds at the end of the procedure, and no supplementation was required.
Amaurosis
At 10 minutes after ASCAN, 10 patients achieved total amaurosis. This reflects significant optic nerve anesthesia in some patients. It was not possible to document relative decrease in vision after ASCAN in the operating theater.
Complications
Advanced subconjunctival anesthesia was generally well tolerated by patients. Some described stinging or pressure, which quickly resolved when the injection was paused. Significant subconjunctival hemorrhage of at least 1 quadrant occurred in 3 patients (5%) but did not compromise surgery. Of these, 1 had an international normalized ratio (INR) of 2.2, whereas 2 were taking antiplatelet therapy. In total, 8 patients (13%) were taking warfarin (INR ranging from 1.6 to 2.7), whereas 21 patients (35%) took aspirin and/or other oral antiplatelet agents.
Chemosis was seen in all patients though it can be minimized as described in our methods. This did not pose a problem to surgery. In 2 patients unintended double puncture of the conjunctiva caused some leakage of local anesthetic injected. There was no perforation of the globe.
Anterior vitrectomy was not required in any cases and no surgical complications occurred. In particular there was no persistent postoperative diplopia or lid ptosis.
DISCUSSION
Ophthalmologists frequently utilize subconjunctival injections to administer various therapeutic substances and anasthetists have been using subconjunctival blocks for decades to provide surface anesthesia in small volumes.
This technique evolved from subconjunctival injections for pterygium surgery. We noticed in some cases when larger volumes (more than 3 mL) were used, there was lid ptosis and a degree of globe akinesia. Later we reviewed the anatomy and developed our current ASCAN technique, with larger volumes directed posteriorly into the sub-Tenon's space.
The Tenon's capsule starts at the limbus anteriorly where for the initial 1.5 mm it is fused to the sclera and conjunctiva. It extends posteriorly to envelop the globe to the optic nerve posteriorly, forming extensions to the lids, orbital septum, and around rectus and oblique muscle sheaths along the way 17 ( Fig. 1 ). There is a potential space between the capsule and the episclera.
Our observations of proptosis, lid ptosis, globe akinesia, and sensory anesthesia suggest that ASCAN takes effect as the local anesthetic spreads around in the sub-Tenon's space and its extensions along neuromuscular sheaths and then into intraorbital fat tissue and the subcutaneous tissue of the lids. The sub-Tenon's space seems to readily accept injected solutions with minimal resistance up to its volume capacity. This spread can be retarded by to the anterior sub-Tenon's space. The ASCAN technique uses elements of single superolateral sub-Tenon's injection described by Fukasaku 20 and larger volumes of anesthetic reported in Ripart's CT scan studies, along with anterior access as suggested by McNeela et al. 21 All 60 patients successfully completed phacoemulsification surgery after receiving single injections of ASCAN without need for supplementation. Fifty-seven (95%) patients had aggregated motor scores of 4 or less out of 15, which is comparable with other methods of sub-Tenon's anesthesia. 14, 15, 22 From our experience, an adequate ASCAN injection will usually require 5 to 10 mL to spread around the sub-Tenon's space and associated orbital structures. Our mean injected volume of 9.6 mL seems relatively large. There are several reasons for this. The first is that much of the volume is taken up in the neuromuscular sheaths and fat tissues of the lids, peribulbar, and subconjunctival areas. Secondly, for the purposes of this study, higher volumes were used to ensure the effectiveness of a new technique could be demonstrated. With further clinical experience, we have found ways of achieving similar clinical results with lower volumes, which will be a subject for future study.
Clinical signs of raised intraocular pressures such as tight orbit or shallow anterior chamber were not seen. A weakness of this study was that intraocular pressure was not measured before and after ASCAN injection. This will be investigated in future studies, but anecdotal evidence suggests this is not a problem. The anterior flow of anesthetic into the subconjunctival and subcutaneous spaces during the infiltration may help to limit pressure rise in the retrobulbar space by providing a natural escape route for excess anesthetic.
Advanced subconjunctival anesthesia also confers other clinical advantages. Reliable lid akinesia minimizes the need for facial nerve block. The site of injection is directly compressible, allowing control of any subconjunctival hemorrhage. This technique has been used intraoperatively to quickly supplement inadequate conventional eye blocks.
The use of a sharp needle adjacent to the sclera is a potential disadvantage to this technique. The risks would seem to be similar to that of a subconjunctival injection and less perilous than a blind posterior retrobulbar or peribulbar injection. The partial connective tissue bands separating the orbit into multiple compartments, 18 resulting in incomplete akinesia as seen in our study. In a study by Ripart et al, 19 2 to 9 mL of contrast was given to fresh cadavers by medial canthus sub-Tenon's injection (Fig. 5) . Subsequently using high-resolution computed tomography (CT) scan, at volumes greater than 4 mL, contrast media was detected around the globe, the dura mater of the optic nerve sheath, rectus muscle sheaths, subconjunctivally, and the lids (including orbicularis oculi and levator palpebrae). Ripart concluded that the fascial sheath of the globe preferentially guides local anesthetic to the above structures, and that chemosis signifies correct needle placement.
Combining the above concepts, we hypothesize that profound globe and lid anesthesia were possible by spreading local anesthetic to relevant neuromuscular structures with an injection Copyright © 2018 Asia-Pacific Academy of Ophthalmology. Unauthorized reproduction of this article is prohibited. insertion of a relatively short needle of 16 mm under direct visualization significantly reduces the risk of perforating the globe or posterior neurovascular structures, including the optic nerve or artery. These features provide a degree of anatomical certainty and clinical safety, particularly for patients with long eyes, past surgery, or anatomical variations. Supplementary injections can be given at any stage with ease using a similar technique in the inferior medial quadrant. Instruments required are minimal, cheap, and widely available, which may be particularly advantageous in developing nations where resources are limited. We have not required the use of speculum, forceps, conjunctival scissors, or proprietary cannula in any of our cases.
Conjunctival edema at the end of the injection may interfere with the operative field. This is minimized by the use of hyaluronidase and focal digital pressure along the gap between the globe and orbital margins to help dissipate the anesthetic. On the other hand, multiple punctures of the conjunctiva may result in leakage of local anesthetic and a poor block.
Another advantage of ASCAN is that focal digital compression over the superior and inferior orbital septae involves less pressure than direct pressure on the globe itself. Techniques using the Honan balloon, folded gauze, or direct digital pressure may significantly increase intraocular pressure and related complications.
A nonrandomized controlled clinical trial is proposed to answer some of the weaknesses of this study. There is a need to demonstrate the use of advanced subconjunctival anesthesia without sedation, using lower anesthetic volumes, and with different anesthetists. Measurement of intraocular pressure before and after ASCAN should be performed to confirm its safety. Its role in glaucoma or retinal surgery remains to be verified. The authors are currently using this technique to supplement anesthesia intraoperatively and for anesthesia during panretinal laser photocoagulation. A recent anatomical study by Kakizaki et al 23 may help to explain the mechanism of action and may suggest more effective injection sites.
In conclusion, ASCAN for phacoemulsification surgery is a variation of subconjunctival block with a visualized injection in the superotemporal quadrant and using a larger volume of anesthetic directed posteriorly in the sub-Tenon's space. In addition to producing a relatively reliable anesthesia, it also achieves akinesia and a degree of optic nerve block. Our results are comparable to other sub-Tenon's anesthesia techniques. It is an alternative, minimally invasive technique that does not require conjunctival dissection or posterior blind instrumentation. Further studies are needed to establish safety and elucidate wider applications of this technique.
